Introduction
Salmonella Typhi, the bacterium responsible for typhoid fever, is highly endemic in regions like the Indian subcontinent. While it typically manifests as a systemic enteric fever, extra-intestinal complications can occur. However, the formation of an isolated soft tissue abscess in the abdominal wall is exceedingly rare, especially in the absence of detectable bacteremia. This case report details such a presentation, highlighting the diagnostic challenges and the role of underlying comorbidities.
Case Presentation
A patient presented with a localized swelling in the left anterior abdominal wall. Diagnostic imaging was employed to characterize the lesion and guide intervention.
Ultrasonography (USG) and a plain abdominal CT scan confirmed a 7.5 x 4.3 cm hypodense abscess in the subcutaneous plane. Initial systemic investigations, including blood and urine cultures and a Widal test, were negative. The patient underwent two rounds of incision and drainage (I/D). While the first procedure yielded sterile pus, the second drainage, performed two weeks later, resulted in the growth of non-lactose fermenting colonies. These were confirmed as Salmonella Typhi through biochemical testing and serotyping (using poly O, monovalent O9, and Vi antisera).
Discussion
The pathogenesis of localized S. Typhi infection without systemic symptoms involves several factors. The patient was a newly diagnosed diabetic, a condition that impairs host immunity and facilitates opportunistic infections. Furthermore, the presence of asymptomatic gallstones likely provided a chronic reservoir for the bacteria; infected bile can harbor S. Typhi subclinically for extended periods.
The authors hypothesize that the bacteria reached the abdominal wall via transient bacteremia that was not captured by standard blood draws. Interestingly, the initial sterile culture followed by a positive one suggests that surgical trauma from the first drainage may have triggered the proliferation of the subclinical infection.
Management was complicated by the strain's resistance profile. The isolate was identified as Nalidixic Acid Resistant S. Typhi (NARST), showing resistance to ampicillin, chloramphenicol, and nalidixic acid. This necessitated a high-dose regimen of ciprofloxacin. The patient responded well to a six-week course of this targeted therapy.
Conclusion
This case emphasizes that clinicians in endemic areas must maintain a high index of suspicion for Salmonella Typhi in atypical soft-tissue infections, even when classic systemic indicators are absent. The emergence of NARST strains underscores the need for precise microbiological diagnosis and susceptibility testing to ensure effective treatment and prevent recurrence.
Summary updated